A diagnostic dilemma: Atypical melanocytic lesions arising in the setting of treatment with the BRAF inhibitor, vemurafenib

Autor: Mary Clark, MD, Paul Imbriano, DO, Michael Harwood, MD, Klaus Busam, MD, Leslie Robinson-Bostom, MD

Publikováno v: JAAD Case Reports, Vol 24, Iss , Pp 32-34 (2022)

Externí odkaz: https://doaj.org/article/4d0425d3b53948cb9b5d3bbc7ec6c4c5

Social Return on Investment of Home Exercise and Community Referral for People With Early Dementia

Autor: Ned Hartfiel PhD, John Gladman DM, Rowan Harwood MD, Rhiannon Tudor Edwards D.Phil

Publikováno v: Gerontology and Geriatric Medicine, Vol 8 (2022)

Exercise can improve physical function and slow the progression of dementia. However, uncertainty exists around the costeffectiveness of exercise programmes for people with early dementia. The aim of this study was to determine whether a home-based s

Externí odkaz: https://doaj.org/article/e3e87c75d4d449b0bce4ad0108755100

Procedure-related miscarriages and down syndrome–affected births: implications for prenatal testing based on women’s preferences 11We thank Virginia Gildengorin, PhD, for statistical support. We also thank Bryna Harwood, MD, James Lewis, MD, Ruth Schaber MD, and David Walton, MD, at Kaiser Permanente, and the following physicians for their participation in this study: Albert L. Brooks, MD, Carol Eades, MD, Chris Grover, MD, Susan Sykes, MD (La Clinica de la Raza); Curtis E. Montgomery, MD, Alex Moy, MD, Lawrence Newman, MD, Laura Norell, MD, M. Ming Quan, MD, Kimberly Sorem, MD, and Jonathan Wong, MD (North East Medical Services).

Autor: Kuppermann, Miriam, Nease, Robert F, Learman, Lee A, Gates, Elena, Blumberg, Bruce, Washington, A.Eugene

Publikováno v: Obstetrics and Gynecology; January 2000, Vol. 96 Issue: 4 p511-516, 6p

Interlaboratory Variability in the Madin-Darby Canine Kidney Cell Proteome.

Autor: Harwood MD; Certara UK Ltd (Simcyp Division), Sheffield S1 2BJ, U.K., Zettl K; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany., Weinheimer M; Quantitative, Translational & ADME Sciences, AbbVie Deutschland GmbH & Co. KG, Ludwigshafen 67061, Germany., Pilla-Reddy V; Clinical Pharmacology and Quantitative Pharmacology, Vaccines and Immunotherapies, Neuroscience and Clinical Immunogenicity, AstraZeneca, Cambridge CB2 0AA, U.K., Shen H; Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, Princeton, New Jersey 08543, United States., Jacobs F; Preclinical Sciences Translational Safety, Janssen Pharmaceutical Companies of Johnson & Johnson, Beerse 2340, Belgium., Chu X; ADME and Discovery Toxicity, Merck & Co., Inc., Rahway, New Jersey 07065, United States., Huth F; Novartis Institutes for BioMedical Research, Basel 4056, Switzerland., Nakakariya M; Global Drug Metabolism and Pharmacokinetics, Takeda Development Center Americas, Inc. (TDCA), 9625 Towne Centre Drive, San Diego, California 92121, United States., Chothe PP; Drug Metabolism and Pharmacokinetics, Vertex Pharmaceuticals, Boston, Massachusetts 02210, United States., Neuhoff S; Certara UK Ltd (Simcyp Division), Sheffield S1 2BJ, U.K., Wiśniewski JR; Biochemical Proteomics Group, Department of Proteomics and Signal Transduction, Max Planck Institute of Biochemistry, Martinsried 82152, Germany.

Publikováno v: Molecular pharmaceutics [Mol Pharm] 2023 Jul 03; Vol. 20 (7), pp. 3505-3518. Date of Electronic Publication: 2023 Jun 07.

Quantification of Proteins Involved in Intestinal Epithelial Handling of Xenobiotics.

Autor: Al-Majdoub ZM; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Couto N; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Achour B; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Harwood MD; Certara UK (Simcyp Division), Sheffield, UK., Carlson G; Gut Barrier Group, Inflammation and Repair, University of Manchester, Salford Royal NHS Trust, Salford, UK., Warhurst G; Gut Barrier Group, Inflammation and Repair, University of Manchester, Salford Royal NHS Trust, Salford, UK., Barber J; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK., Rostami-Hodjegan A; Centre for Applied Pharmacokinetic Research, School of Health Sciences, University of Manchester, Manchester, UK.; Certara UK (Simcyp Division), Sheffield, UK.

Publikováno v: Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Apr; Vol. 109 (4), pp. 1136-1146. Date of Electronic Publication: 2020 Dec 05.